Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $110M+ oversubscribed Series B (Nov 2025). SAKURA-X chiplet platform samples end 2026. TDK Ventures strategic investor. Edge AI chips in production (SAKURA-II).
EdgeCortix is a Tokyo-based edge AI semiconductor company with silicon already in production and a credible next-generation chiplet roadmap. The company raised $110 million+ in an oversubscribed Series B in November 2025, with TDK Ventures joining as a strategic investor — providing access to TDK's manufacturing and distribution relationships in Asia. The SAKURA-II edge AI chip is in commercial production, with the next-generation SAKURA-X chiplet platform targeting samples by end of 2026.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.